The Canadian Licensed Producer (LP) component of the munKNEE Pure-Play Pot Stock Index has 9 constituents and they continued to decline across the board this past week ranging from -6.2% to -16.6% and averaging a full -14.5%. That being said, the Index was still up 5.7% for the month of February. 

LP Pure-Play Pot Stock Index Performance

The constituent declines last week were as follows, in descending order, with price changes for the month of February in brackets:

1. Tilray (TLRY): -16.6% to $24.36/share (+34.6%)
   • Q4 financial results (see here)
   • 12 analysts on Yahoo Finance have forecast price targets ranging from zero to $24.20 with an average price target of $10.97 per share
2. Cronos (CRON): -14.8% to $10.48/share (+1.3%)
   • Q4 financial results (see here)
3. Canopy (CGC): -15.2% to $32.75/share (-18.3%)
   • Q3 financial results (see here)
4. Organigram (OGI): -13.9% to $3.03/share (+65.6%)
5. Aurora (ACB): -13.8% to $10.52/share (-5.7%)
   • Q2 financial results (see here)
6. Hexo (HEXO): -13.1% to $7.74/share (+10.1%)
   • bought Zenabis Global Inc. in an all-stock deal valued at approximately $235 million
7. Rubicon (ROMJF) -12.2% to $2.51/share (N/C)
   • closed its previously announced bought deal public offering for aggregate gross proceeds of approximately $23 million
8. Aphria (APHA): -11.9% to $17.84/share (+46.5%)
   • Stifel analyst Andrew Carter increased the stock’s target price to $15.50, up from $9.80, and maintained a neutral rating on it
9. Valens (VLNCF): -6.2% to $1.37/share (-2.8.0%)
   • Q4 financial results (see here)

(For more extensive financial information, charts, news releases and articles, and up-to-the-minute stock prices click on the stock symbols provided by TalkMarkets. All currency amounts are in U.S. dollars. Go here to convert to another currency.)